SLS · SELLAS Life Sciences Group, Inc. · Executive Compensation
$11.33
-0.02 (-0.18%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$2.45B
Shares
201.95M
Volume · Oct 22
6.51M
Avg daily vol (3M)
6.5M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Angelos M. Stergiou | M.D., Sc.D. h.c. President and Chief Executive Officer | $1,877,810 |
| Dragan Cicic | M. D. Senior Vice President, Chief Development Officer | $991,795 |
| John T. Burns | Senior Vice President, Chief Financial Officer | $959,653 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Angelos M. Stergiou | M.D., Sc.D. h.c. President and Chief Executive Officer | $1,189,773 |
| Dragan Cicic | M. D. Senior Vice President, Chief Development Officer | $713,480 |
| John T. Burns | Senior Vice President, Chief Financial Officer | $680,778 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Angelos M. Stergiou | M.D., Sc.D. h.c. President and Chief Executive Officer | $1,752,638 |
| Barbara A. Wood | Former Executive Vice President, General Counsel and Corporate Secretary | $913,920 |
| John T. Burns | Senior Vice President, Chief Financial Officer | $797,708 |
| Dragan Cicic | M. D. Senior Vice President, Chief Development Officer | $778,507 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Angelos M. Stergiou | M.D., Sc.D. h.c. President and Chief Executive Officer | $1,952,245 |
| Barbara A. Wood | Former Executive Vice President, General Counsel and Corporate Secretary | $937,055 |
| John T. Burns | Senior Vice President, Chief Financial Officer | $659,844 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Angelos M. Stergiou | M.D., Sc.D. h.c. President and Chief Executive Officer | $1,426,610 |
| Barbara A. Wood | Executive Vice President, General Counsel and Corporate Secretary | $705,672 |
| Nicholas J. Sarlis | M.D., Ph.D., FACP Former Executive Vice President and Chief Medical Officer | $445,617 |
| John T. Burns | Vice President, Finance and Corporate Controller | $436,727 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Angelos M. Stergiou | M.D., Sc.D. h.c. President and Chief Executive Officer | $1,240,307 |
| Nicholas J. Sarlis | M.D., Ph.D., FACP Former Executive Vice President and Chief Medical Officer | $783,304 |
| Barbara A. Wood | Executive Vice President, General Counsel and Corporate Secretary | $630,684 |
| John T. Burns | Vice President, Finance and Corporate Controller | $393,334 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Robert Francomano | Senior Vice President and Chief Commercial Officer | Terminated | 2024-03-08 |
| Barbara A. Wood | Executive Vice President, General Counsel and Corporate Secretary | Terminated | 2024-03-08 |
| John T. Burns | Chief Financial Officer and principal financial officer | Appointed | 2023-02-06 |
| Katherine Bach Kalin | member of the Board | Appointed | 2022-08-16 |
Leadership
- Angelos M. Stergiou CEO, Board Member
- John T. Burns CFO, Chief Accounting Officer
- David A. Scheinberg Board Member
- Jane Wasman Board Member
- Katherine Bach Kalin Board Member
- Robert L. Van Nostrand Board Member
Key facts
CIK
1390478
CUSIP
81642T209
13F (30d)
33 filings
33 filers
Visit website
Investor relations